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This article refers to ‘Inotropic myocardial reserve defi-
ciency is the predominant feature of exercise haemody-
namics in cardiac amyloidosis’ by T.S. Clemmensen et al.,
published in this issue on pages 1457–1465.
Cardiac amyloidosis (CA) has been traditionally considered a
restrictive cardiomyopathy and a typical cause of diastolic heart
failure or, better, of ‘heart failure with preserved ejection fraction’
(HFpEF).1 In recent years, however, various observations have
challenged this paradigm:
• Left ventricular (LV) ejection fraction (EF) in CA varies quite
widely and is <50% in more than 40% of cases.2,3
• Left ventricular longitudinal function is impaired from a rela-
tively early phase of the disease, even in cases with normal
circumferential function (normal EF).3
• Left ventricular torsion and strain rate are often abnormal.3,4
• Myocardial infiltration is not the only pathogenetic mechanism
responsible for cardiac dysfunction. A direct toxic effect of
circulating precursor proteins on cardiomyocytes has been
demonstrated in primary light chain related (AL) disease.5,6
The work of Clemmensen et al.7 published in this issue of the
Journal offers a further insight into the complex pathophysiology
of CA. The principal merit of the study is the direct evaluation of
central haemodynamics both at rest and during exercise in a group
of patients with CA due to various aetiologies: AL, wild-type, or
mutant transthyretin CA. Although it is well known1,8 that many
patients with so-called diastolic dysfunction have a normal or mildly
elevated LV filling pressure at rest and that symptoms will develop
with physical activity because of rising filling pressures—needed
to maintain an adequate stroke volume—this is the first study to
provide such an in-depth evaluation of cardiac performance in CA.
Although LV EF at rest was preserved in all the cases and
pulmonary capillary wedge pressure was abnormal in only 50%
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. of patients, exercise unmasked an abnormal haemodynamic
response in the vast majority of patients, characterised by
increased left- and right-sided filling pressures (more pronounced
in the right heart), impaired inotropic reserve, and reduced pul-
monary arterial compliance. This exercise-induced haemodynamic
derangement was significantly related to the reduced exercise
capacity of the patients. In detail, despite an adequate increase in
LV filling pressure, CA patients were unable to increase stroke
volume during exercise and this was accompanied by reduced
myocardial efficiency. The authors interpret this finding as an
expression of reduced inotropic reserve. This is probably true
and exercise-induced myocardial ischaemia secondary to amy-
loidotic infiltration of coronary arteries at the microvascular level
could be one of the mechanisms involved (not explored in this
study design). Unfortunately, LV volumes were not measured in
this study and no direct information on volumes and EF during
exercise is provided. It is, however, highly probable that LV filling
during exercise is also limited, since the increase in filling pressure
is not sufficient to induce an adequate stretching of the ventricular
wall. Therefore, it could be hypothesized that a combination of
absence of increase in end-diastolic volume and a limited or absent
decrease in end-systolic volume is responsible for the observed
absent or limited increase in stroke volume.
Notably, the limited increase in heart rate during exercise (1.6
times among CA patients vs. 2.5 in normal controls) could partly
explain the limited increase in cardiac output during exercise.
The demonstration of a significant reduction in pulmonary
arterial compliance during exercise is another key finding of the
study of Clemmensen et al.7 The Authors intriguingly argue that
this could be a consequence of pulmonary vascular amyloidotic
infiltration and not merely due to excessive pulmonary arterial
vasoconstriction. It is known that right ventricular function is an
independent determinant of prognosis in CA and other conditions
with HFpEF.9,10 Since the right ventricle—infiltrated by amyloidosis
as the left ventricle—is very dependent on loading conditions,
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Table 1 Pathogenesis of amyloidotic cardiomyopathy
Main pathophysiological mechanisms
• Infiltration of myocardium leading to reduced deformability
• Infiltration of atrioventricular valves, coronary and pulmonary
circulation
• Direct toxic effect of precursor proteins on myocardial cells
• Reduced cardiac sympathetic innervation
Other cardiovascular effects
• Reduced pulmonary compliance
• Reduced atrial passive function
• Reduced atrial active function
• Atrial fibrillation/flutter
• Bradyarrhythmia and chronotropic incompetence
• Atrioventricular valve regurgitation
• Microvascular myocardial ischaemia
Effects on left and right ventricular function
• Reduced longitudinal function
• Reduced circumferential function
• Reduced torsion
• Reduced ventricular filling
• Reduced inotropic and preload reserve
Effects on the most used indexes of cardiac function at rest
• Restrictive filling pattern at echo Doppler
• Increased filling pressures
• Reduced S wave
• Reduced e’ wave
• Increased E/e’
• Reduced global longitudinal strain (with apical sparing)
• Reduced ejection fraction
• Reduced stroke volume/cardiac output
• Reduced myocardial contraction fraction
Effects on the most used indexes of cardiovascular function during
exercise
• Reduced exercise tolerance (oxygen consumption; 6-minute
walk test)
• Further increase in filling pressures
• Inadequate increase in cardiac output
reduced pulmonary arterial compliance has major consequences
for right ventricular function and increases the risk for late right
ventricular failure.
Considering these findings alongside other recent studies on
cardiac function in CA,2–6,8–12 a complex and intriguing sce-
nario emerges. To better understand this interplay, we need to

































































.. as well as their effects on the different components of cardiac
pathophysiology and on the various indexes of cardiac function
both at rest and during exertion. Table 1 summarizes these three
different—albeit interrelated—levels.
In conclusion, despite the fact that exercise testing is not often
used and requires a greater effort from both the patient and the
physician, in CA it does not only lead to greater pathophysiological
comprehension, but also to a more comprehensive assessment of
the patient and can aid decision-making.
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